The Biggest Psychedelic News Stories of the Week – June 30
In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity and acceptance.
In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity and acceptance.
Elon Musk takes ketamine in small doses to treat depression and uses higher doses of the drug at social occasions, according to The Wall Street Journal.
This is one of the billionaire’s most explicit acknowledgments of the power of psychedelics for mental health applications.
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.